Sep 24, 2016

Week in Review: Jacobson Pharma Raises $85 Million in Hong Kong IPO - ChinaBio® Today

Jacobson Pharma, Hong Kong's largest generic company, completed an $85 million IPO on the Hong Kong exchange; TenNor Therapeutics of Suzhou announced a $25 million Series B financing for its novel dual-acting antibiotic platform; Golden Meditech will invest $20 million in an autoimmune-focused JV that combines its China cord blood banking operation and Houston's MD Anderson Cancer Center;...

Proceed to the page:

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed